Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2010
04/22/2010WO2010045462A1 System for identification of multiple nucleic acid targets in a single sample and use thereof
04/22/2010WO2010045420A1 Methods for detecting sulfhydryl-containing compounds in a biological test sample
04/22/2010WO2010045389A1 Method and apparatus for increasing adipose vascular fraction
04/22/2010WO2010045357A2 Enhanced on-chip sers based biomolecular detection using electrokinetically active microwells
04/22/2010WO2010045323A2 A novel sorting technology that allows for highly efficient selection of sperm without chromatin damage
04/22/2010WO2010045270A2 Compositions for labeling and identifying autophagosomes and methods for making and using them
04/22/2010WO2010045234A1 Methods of optimizing treatment of estrogen-receptor positive breast cancers
04/22/2010WO2010045224A2 Methods for the selection of therapeutic treatments for cancer
04/22/2010WO2010045180A1 Biomarkers for inflammatory bowel disease and methods using the same
04/22/2010WO2010045024A1 Biomarkers and methods for detecting and treating spinal and joint pain
04/22/2010WO2010044932A2 Nanofluidic channels with integrated charge sensors and methods based thereon
04/22/2010WO2010044752A1 Amphiphilic polymers and nanocrystals coated therewith
04/22/2010WO2010044745A1 Process and device for automated grading of bio-specimens
04/22/2010WO2010044744A1 Novel thiophene compounds for in vivo imaging
04/22/2010WO2010044689A2 Integrated screening methods for identifying modulators of mineralization, and modulators identified therefrom
04/22/2010WO2010044686A1 Akr1c3 as a biomarker, methods of selecting and treating patients based upon an akr1c3 profile and compounds for use therein
04/22/2010WO2010044650A1 Mobile device and interactive universal classification method for meat using computer vision
04/22/2010WO2010044101A1 Purification and assay for topoisomerases and use of the assay for screening modulators of topoisomerases
04/22/2010WO2010044080A2 Procedure to estimate organoleptic parameters of tissues of animal origin and device for carrying out same
04/22/2010WO2010044007A2 Pulsed magnetic actuation for sensitive assays
04/22/2010WO2010044005A2 Method and device for determining the amount of magnetically labeled target components
04/22/2010WO2010043985A1 Non-enzymatic electrochemical method for simultaneous determination of total hemoglobin and glycated hemoglobin
04/22/2010WO2010043973A2 Biomarkers for dengue
04/22/2010WO2010043927A1 Method for the preparation of immunoconjugates and use thereof
04/22/2010WO2010043896A1 Method of toc monitoring
04/22/2010WO2010043825A1 Determination of the salt concentration of an aqueous solution
04/22/2010WO2010043824A1 Process for the determination of the solid/liquid phase
04/22/2010WO2010043724A1 Method for identifying allergenic proteins and peptides
04/22/2010WO2010043713A2 Use of cyclin o in a medical setting
04/22/2010WO2010043668A1 Dried blood spots for blood analysis
04/22/2010WO2010043643A1 Analysis device with user-friendly menu controls
04/22/2010WO2010043615A1 Gravimetric sensor having a sensitive layer containing a diamond nanopowder
04/22/2010WO2010043393A1 Use of biglycan in the assessment of heart failure
04/22/2010WO2010043224A1 Detection of carcinoma in situ in semen specimens
04/22/2010WO2010043113A1 Method for separating red blood cells from blood samples and use thereof
04/22/2010WO2010043112A1 Preparation and its use of derivatisation reagent for detecting l-carnitine or d-carnitine
04/22/2010WO2010043075A1 Liquid test strip and the method
04/22/2010WO2010043074A1 A fluid test strip and method thereof
04/22/2010WO2010043065A1 Device and method for determining a dielectric property of a capacitor arrangement
04/22/2010WO2010043064A1 Device and method for determining a dielectric property of a capacitor arrangement
04/22/2010WO2010043063A1 Capacitive measuring circuit for yarn inspection
04/22/2010WO2010043053A1 Single-domain antibody functionalized quantum dots for cellular imaging of cancer cells
04/22/2010WO2010043044A1 Downward or vertical flow diagnostic device and assay
04/22/2010WO2010043037A1 Formulations targeting igfbp7 for diagnosis and therapy of cancer
04/22/2010WO2010043021A1 Method of identifying endogenous fluorescent biological markers for monitoring cells
04/22/2010WO2010027260A3 Biomarkers for identifying subjects predisposed to developing insulin resistance and determining the insulin resistance status
04/22/2010WO2010025340A3 Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel
04/22/2010WO2010019550A3 Method of identifying disease risk factors
04/22/2010WO2010019515A3 Digital light processing hyperspectral imaging apparatus
04/22/2010WO2010017500A3 Anti-pancreatic cancer antibodies
04/22/2010WO2010015592A3 Bioassay for polyq protein
04/22/2010WO2010014225A3 Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
04/22/2010WO2010011299A3 Nanostructured optical fiber illumination systems and methods for biological applications
04/22/2010WO2010009271A3 Glycan arrays on ptfe-like aluminum coated glass slides and related methods
04/22/2010WO2010008895A3 Per3 as a biomarker for prognosis of er-positive breast cancer
04/22/2010WO2009158618A3 Avian reoviridae
04/22/2010WO2009158040A3 Cancer platinum resistance detection and sensitization method
04/22/2010WO2009155021A3 Methods and assays for oversulfated glycosaminoglycans
04/22/2010WO2009152463A3 Method for screening for compounds that inhibit neurodegeneration
04/22/2010WO2009152389A3 Systems and methods to perform inhibition diagnostic testing
04/22/2010WO2009148590A3 A creature-machine hybrid detector system for the autonomous and multimodal detection of illicit and hazardous materials
04/22/2010WO2009145815A4 Biomarkers of ovarian cancer
04/22/2010WO2009143155A3 Delayed fruit deterioration allele in plants and methods of detection
04/22/2010WO2009140364A3 Methods for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin d synthase
04/22/2010WO2009138466A3 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
04/22/2010WO2009137674A3 Treating myelin diseases with optimized cell preparations
04/22/2010WO2009126306A3 Compositions and methods for detecting egfr mutations in cancer
04/22/2010WO2009121845A3 Method to design and uses of overlapping peptides for monitoring t-cell responses in hiv patients
04/22/2010WO2009117522A3 Nanopore and carbon nanotube based dna sequencer and a serial recognition sequencer
04/22/2010WO2009114699A3 High molecular weight ngal as a biomarker for chronic kidney disease
04/22/2010WO2009112670A3 Use of a protein or nitrated peptide sequence for implementing a diagnosis method
04/22/2010WO2009102366A3 Expression of orphan gpr64 in inflammatory diseases
04/22/2010WO2008154207A9 Methods and compounds for regulating apoptosis
04/22/2010WO2006083305A8 Methods and compositions for the detection of biological molecules using a two particle complex
04/22/2010US20100100985 Methods and Compositions for Increasing the Nitrogen Storage Capacity of a Plant
04/22/2010US20100100974 Models of Malignant Brain Cancer, and Therapeutic siRNAs Against Oncogenic Signaling Pathways, and Methods and Kits for Uses Therefor
04/22/2010US20100100973 Cranial and vertebral defects associated with loss-of-function of nell1
04/22/2010US20100100580 Blood Glucose Tracking Apparatus and Methods
04/22/2010US20100100332 Determination of melting temperatures by equation-less methods
04/22/2010US20100099853 Multivalent Antibody Constructs
04/22/2010US20100099831 Solid phase immobilized trifunctional linker
04/22/2010US20100099737 Compositions and methods for treating myelosuppression
04/22/2010US20100099726 Inhibitors of pyruvate kinase and methods of treating disease
04/22/2010US20100099613 Peptides for inducing a ctl and/or htl response to hepatitis c virus
04/22/2010US20100099575 Novel polypeptide scaffolds and use thereof
04/22/2010US20100099574 Methods of identifying an analyte and nucleic acid analysis
04/22/2010US20100099203 Substrates with surfaces modified with PEG
04/22/2010US20100099202 DETECTION OF VON-WILLEBRAND FACTOR (vWF) ACTIVITY
04/22/2010US20100099201 Methods and compositions relating to isocyanate conjugates
04/22/2010US20100099200 Direct mass spectrometric analysis of drug candidates targeting protein complexes
04/22/2010US20100099197 Systems for genome selection
04/22/2010US20100099196 Process for normalizing the concentration of analytes in a urine sample
04/22/2010US20100099195 Zinc-Based Screening Test and Kit for Early Diagnosis of Prostate Cancer
04/22/2010US20100099193 System and method for monitoring and controlling quality of culture water and integrated water quality analyzer thereof
04/22/2010US20100099192 Test-sensor cartridge
04/22/2010US20100099188 Dual Inhibitors of HIV-1 gp-120 Interactions
04/22/2010US20100099184 Polynucleotides encoding class ii cytokine receptor-7
04/22/2010US20100099168 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex
04/22/2010US20100099129 Transcobalamin II assay method
04/22/2010US20100099124 Method for Diagnosing Diseases Based on Levels of Anti-Glycan Antibodies